<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' version='2.0'><channel><atom:id>tag:blogger.com,1999:blog-4464918276887546085</atom:id><lastBuildDate>Tue, 20 Oct 2009 14:48:28 +0000</lastBuildDate><title>Depression Treatment</title><description>Depression Treatment Blog Provides Daily Updated News, Information &amp; Articles About Depression Treatment And Aid Along With Case Studies And In-depth Analysis Of Several Interesting Cases.</description><link>http://depression-aid.blogspot.com/</link><managingEditor>noreply@blogger.com (Ruslan Abuzant)</managingEditor><generator>Blogger</generator><openSearch:totalResults>1055</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-5744998227929597777</guid><pubDate>Mon, 02 Jun 2008 02:08:00 +0000</pubDate><atom:updated>2008-06-01T19:08:10.869-07:00</atom:updated><title>Coalition tests program to treat depression</title><atom:summary type='text'>MINNEAPOLISóIn an attempt to address an estimated $44 billion that U.S. employers lose in productivity a year due to employee depression, Bridges to Excellence this week is launching a pay-for-performance program that will reward physicians for providing optimal treatment of the condition.From: www.businessinsurance.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/06/coalition-tests-program-to-treat.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>1</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-568667882441315128</guid><pubDate>Sun, 01 Jun 2008 10:48:00 +0000</pubDate><atom:updated>2008-06-01T03:48:15.128-07:00</atom:updated><title>Teva launches generic Wellbutrin in smaller dose</title><atom:summary type='text'>US sales of the smaller dosage totaled $930 million over 12 months.From: www.globes.co.il   </atom:summary><link>http://depression-aid.blogspot.com/2008/06/teva-launches-generic-wellbutrin-in.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-4559521024132793544</guid><pubDate>Wed, 28 May 2008 23:18:00 +0000</pubDate><atom:updated>2008-05-28T16:18:08.353-07:00</atom:updated><title>Employer group launches depression treatment plan</title><atom:summary type='text'>MINNEAPOLIS?Employer coalition Bridges to Excellence is launching a pay-for-performance program that will reward physicians for optimal treatment of depression.From: www.businessinsurance.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/employer-group-launches-depression.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-156545857794184602</guid><pubDate>Wed, 28 May 2008 01:02:00 +0000</pubDate><atom:updated>2008-05-27T18:02:08.499-07:00</atom:updated><title>Groundbreaking Approach for Improving Depression Care Introduced at 10 Minnesota Clinics</title><atom:summary type='text'>Ten primary care clinics in the Twin Cities, Duluth and Rochester are the first in Minnesota to offer a new, more effective approach for caring for patients with depression. To date, 234 patients have been enrolled in the program -- called Depression Improvement Across Minnesota, Offering a New Direction, or "DIAMOND" -- since it began in March.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/groundbreaking-approach-for-improving.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-1536223908836421088</guid><pubDate>Wed, 21 May 2008 22:48:00 +0000</pubDate><atom:updated>2008-05-21T15:48:10.292-07:00</atom:updated><title>Mental health levy set for ballot</title><atom:summary type='text'>If only getting approval from Wood County voters were so easy.The Wood County Alcohol, Drug Addiction and Mental Health Services...From: www.sent-trib.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/mental-health-levy-set-for-ballot.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-9218298187332004443</guid><pubDate>Fri, 09 May 2008 20:55:00 +0000</pubDate><atom:updated>2008-05-09T13:56:16.489-07:00</atom:updated><title>Depression topic of SIfCC luncheon</title><atom:summary type='text'>Sixteen representatives from 14 different faith groups joined the board of directors and staff from the Stillwater Interfaith Counseling Center (SIfCC) for their spring luncheon.From: www.stillwater-newspress.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/depression-topic-of-sifcc-luncheon.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-7275549275549008257</guid><pubDate>Fri, 09 May 2008 20:53:00 +0000</pubDate><atom:updated>2008-05-09T13:53:57.479-07:00</atom:updated><title>Mylan shares dip as the company cuts profit guidance</title><atom:summary type='text'>Shares of Mylan Inc. fell Friday after the generic drug developer cut its profit guidance spanning the next several years, though Wall Street expects the company to meet the new targets.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/mylan-shares-dip-as-company-cuts-profit.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-3447225804745861920</guid><pubDate>Thu, 08 May 2008 14:31:00 +0000</pubDate><atom:updated>2008-05-08T07:31:55.456-07:00</atom:updated><title>Depression diversity: Brain studies reveal big differences among individuals</title><atom:summary type='text'>ANN ARBOR, Mich. - Depressed people may have far fewer of the receptors for some of the brain?s ?feel good? stress-response chemicals than non-depressed people, new University of Michigan Depression Center research shows.From: www.eurekalert.org   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/depression-diversity-brain-studies.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-9189306016791256017</guid><pubDate>Wed, 07 May 2008 19:09:00 +0000</pubDate><atom:updated>2008-05-07T12:09:52.841-07:00</atom:updated><title>AFX UK Focus) 2008-05-07 07:46 Lundbeck Q1 EBIT beats consensus; reiterates full-year guidance</title><atom:summary type='text'>COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Lundbeck AS posted first-quarter EBIT of 924 million Danish crowns, up 40 percent from a year earlier on the back of stronger sales and margins, and significantly ahead of consensus estimates according to RB Boersen for 699 million crowns.From: www.iii.co.uk   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/afx-uk-focus-2008-05-07-0746-lundbeck.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-1615972264125888958</guid><pubDate>Wed, 07 May 2008 19:07:00 +0000</pubDate><atom:updated>2008-05-07T12:07:53.186-07:00</atom:updated><title>Depression Treatments Reviewed by NeuroInvestment</title><atom:summary type='text'>NeuroInvestment today announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly aversive side effects for the majority.From: </atom:summary><link>http://depression-aid.blogspot.com/2008/05/depression-treatments-reviewed-by.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-7809826517619554574</guid><pubDate>Mon, 05 May 2008 07:37:00 +0000</pubDate><atom:updated>2008-05-05T00:37:50.387-07:00</atom:updated><title>Kids And Health: Treatment for depression has improved</title><atom:summary type='text'>It is estimated that at some point, 10 percent to 15 percent of children and adolescents have some symptoms of depression. The bad news is that major depression in children is very serious. The good news is that depression is treatable.From: seattlepi.nwsource.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/kids-and-health-treatment-for.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-5656667673334255997</guid><pubDate>Thu, 01 May 2008 12:55:00 +0000</pubDate><atom:updated>2008-05-01T05:55:49.826-07:00</atom:updated><title>Wyeth research chief Ruffolo to retire</title><atom:summary type='text'>NEW YORK, April 30 - Wyeth on Wednesday said its pharmaceuticals research chief Robert Ruffolo will retire later this year and be replaced by Mikael Dohlsten, a former senior executive of privately held German drugmaker Boehringer Ingelheim.From: sg.news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/wyeth-research-chief-ruffolo-to-retire.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-8720551091028132121</guid><pubDate>Thu, 01 May 2008 12:53:00 +0000</pubDate><atom:updated>2008-05-01T05:53:48.684-07:00</atom:updated><title>Sanofi-Aventis 1Q profits hurt by generic competition</title><atom:summary type='text'>French drug maker Sanofi-Aventis on Wednesday reported a 12 percent drop in first-quarter adjusted net profit as the weak dollar and generic competition bit into sales of its sleep and cancer drugs.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/05/sanofi-aventis-1q-profits-hurt-by.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-159040837784004397</guid><pubDate>Tue, 29 Apr 2008 13:43:00 +0000</pubDate><atom:updated>2008-04-29T06:43:46.101-07:00</atom:updated><title>Eli Lilly profit doubles as drug sales rise</title><atom:summary type='text'>INDIANAPOLIS ? Eli Lilly &amp; Co. said Monday its first-quarter profit doubled on sales of depression treatment Cymbalta and impotence drug Cialis, as well as fewer charges, but results missed Wall Street expectations.From: www.thestar.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/eli-lilly-profit-doubles-as-drug-sales.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-441946152906091643</guid><pubDate>Sat, 26 Apr 2008 06:57:00 +0000</pubDate><atom:updated>2008-04-25T23:57:44.772-07:00</atom:updated><title>Sector Wrap: Cost cuts, weak dollar drive pharma earnings</title><atom:summary type='text'>The week saw a flurry of quarterly earnings reports from the pharmaceutical sector, many marred by lower revenue in the face of rising generic competition.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/sector-wrap-cost-cuts-weak-dollar-drive.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-3211403998314228232</guid><pubDate>Wed, 23 Apr 2008 22:27:00 +0000</pubDate><atom:updated>2008-04-23T15:27:43.322-07:00</atom:updated><title>Sector Snap: Schering-Plough, Glaxo boost pharma stocks</title><atom:summary type='text'>Positive earnings reports from Schering-Plough Corp. and GlaxoSmithKline PLC lifted big pharma stocks Wednesday after several days of mixed results from their peers.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/sector-snap-schering-plough-glaxo-boost.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-1534555540103418527</guid><pubDate>Wed, 23 Apr 2008 03:39:00 +0000</pubDate><atom:updated>2008-04-22T20:39:41.685-07:00</atom:updated><title>Wyeth profit hurt by generics</title><atom:summary type='text'>Wyeth posted slightly lower first-quarter earnings on Tuesday, hurt by the recent launch of generic forms of its Protonix ulcer drug, but surprisingly strong sales of other medicines enabled the company to beat Wall Street profit forecasts.From: news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/wyeth-profit-hurt-by-generics.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-4978175288258846879</guid><pubDate>Wed, 23 Apr 2008 03:37:00 +0000</pubDate><atom:updated>2008-04-22T20:37:42.236-07:00</atom:updated><title>Wyeth profit slips, hurt by generic Protonix</title><atom:summary type='text'>Wyeth on Tuesday said its first-quarter net profit fell slightly, hurt by the sudden launch early this year of a generic form of its Protonix ulcer drug, but surprisingly strong sales enabled the company to beat Wall Street profit forecasts.From: news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/wyeth-profit-slips-hurt-by-generic.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-6592661428398903590</guid><pubDate>Tue, 22 Apr 2008 05:07:00 +0000</pubDate><atom:updated>2008-04-21T22:07:41.565-07:00</atom:updated><title>Eli Lilly Profit Doubles on Higher Sales</title><atom:summary type='text'>First-quarter earnings jumped to $1.06 billion, helped by strong sales of Lilly?s Cymbalta and Cialis drugs, but the results missed Wall Street expectations.From: biz.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/eli-lilly-profit-doubles-on-higher.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-6599703728617736408</guid><pubDate>Mon, 21 Apr 2008 23:31:00 +0000</pubDate><atom:updated>2008-04-21T16:31:41.626-07:00</atom:updated><title>Eli Lilly 1Q profit doubles, but falls short of expectations</title><atom:summary type='text'>Drug maker Eli Lilly and Co. said strong sales for Cymbalta and Cialis helped double its first-quarter profit, but results missed Wall Street expectations.From: news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/eli-lilly-1q-profit-doubles-but-falls.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-3904518679517369463</guid><pubDate>Mon, 21 Apr 2008 23:29:00 +0000</pubDate><atom:updated>2008-04-21T16:29:41.260-07:00</atom:updated><title>Eli Lilly says fewer charges, higher sales of Cialis, Cymbalta help push earnings higher</title><atom:summary type='text'>INDIANAPOLIS - Eli Lilly says first-quarter profit doubled on strong growth in sales of depression treatment Cymbalta and impotence drug Cialis, as well as fewer charges.From: www.startribune.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/eli-lilly-says-fewer-charges-higher.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-2176162213057202621</guid><pubDate>Mon, 21 Apr 2008 23:27:00 +0000</pubDate><atom:updated>2008-04-21T16:27:41.706-07:00</atom:updated><title>St. Jude wins patent on depression treatment</title><atom:summary type='text'>St. Jude Medical Inc. said Monday it was awarded a patent for a treatment it has developed for depression. (STJ)From: www.bizjournals.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/st-jude-wins-patent-on-depression.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-879932321604981643</guid><pubDate>Mon, 21 Apr 2008 23:25:00 +0000</pubDate><atom:updated>2008-04-21T16:25:40.912-07:00</atom:updated><title>Analysts: Drug maker earns get temporary lift amid problems</title><atom:summary type='text'>Major drug companies saw their bottom lines buoyed by a weak dollar, one-time gains and other temporary items, but their shares still fell because of basic economic problems hurting the industry.From: news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/analysts-drug-maker-earns-get-temporary.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-8592903274639953399</guid><pubDate>Mon, 21 Apr 2008 23:23:00 +0000</pubDate><atom:updated>2008-04-21T16:23:41.447-07:00</atom:updated><title>Eli Lilly 1Q profit doubles as Cialis, Cymbalta sales rise</title><atom:summary type='text'>INDIANAPOLIS - Eli Lilly &amp; Co. said Monday its first-quarter profit doubled on sales of depression treatment Cymbalta and impotence drug Cialis, as well as fewer charges, but results missed Wall Street expectations.From: nwitimes.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/eli-lilly-1q-profit-doubles-as-cialis.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item><item><guid isPermaLink='false'>tag:blogger.com,1999:blog-4464918276887546085.post-7854990883193705150</guid><pubDate>Fri, 18 Apr 2008 20:43:00 +0000</pubDate><atom:updated>2008-04-18T13:43:39.144-07:00</atom:updated><title>Talk Therapy Proves Effective for Terminal Cancer Patients</title><atom:summary type='text'>FRIDAY, April 18 (HealthDay News) -- Talk therapy can help treat depression symptoms in patients with terminal cancer, according to Japanese researchers who reviewed the results of six studies that included a total of 517 patients with incurable cancer and depression.From: news.yahoo.com   </atom:summary><link>http://depression-aid.blogspot.com/2008/04/talk-therapy-proves-effective-for.html</link><author>noreply@blogger.com (Ruslan Abuzant)</author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></item></channel></rss>